在老年人关节骨折手术中术前高血糖和术后不良事件:血糖值和暴露持续时间
Yazhou Liu1, Ying Yang2, Yuhao Li3
1Department of Orthopedics, Dalian Medical University, Dalian, China; Department of Orthopedics, Dandong Central Hospital, Dalian Medical University, Dandong, China.
Maturitas
|November 28, 2025
概括
在老年关节骨折患者中,高手术前血糖增加了压力 (PU) 和妄 (POD) 的风险. 在手术前管理血糖对于更好的结果和更短的住院时间至关重要.
科学领域:
- 老年人手术是一门老年手术.
- 整形外科手术 整形外科手术
- 麻醉学 麻醉学
背景情况:
- 手术前的血糖与老年手术患者的不良事件有关.
- 在骨骨折手术后对术后压力 (PU),妄 (POD) 和停留时间 (LOS) 的具体影响需要澄清.
研究的目的:
- 调查手术前血糖水平与老年关节骨折患者手术后PU,POD和长期LOS发生率之间的关联.
主要方法:
- 骨骨折患者的回顾性队列研究 (2017-2024年).
- 作为连续和分类变量的手术前血糖的分析.
- 统计方法包括多变量逻辑回归,倾向得分匹配和通用线性模型.
主要成果:
- 每增加1mmol/L的手术前血糖与21%的PU风险增加和28%的POD风险增加相关.
- 住院时间每增加1mmol/L的手术前血糖增加0.54天.
- 在特定的子组中观察到更强的关联,干预的临界值为6.09 mmol/L (PU/LOS) 和6.17 mmol/L (POD).
结论:
- 术前高血糖是老年关节骨折患者术后PU,POD和LOS的重要危险因素.
- 早期的葡萄糖管理,特别是在高风险人群中,可以潜在地减轻术后不良事件.
相关概念视频
Hypoglycemia and Glucagon
778
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
778
Oral Hypoglycemic Agents: Biguanides and Glitazones
565
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
565
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
509
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
509
Oral Hypoglycemic Agents: Glinides
572
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
572
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K


